{"database": "lobbying", "table": "lobbying_activities", "rows": [[3060522, "df288bd3-0d61-4dd2-a4c0-f7c14b8c023f", "Q3", "FOLEY & LARDNER LLP", 15042, "BLINK HEALTH LTD (A BERMUDA LIMITED COMPANY)", 2023, "third_quarter", "PHA", "Market-based solutions to drug pricing and chain pharmacy barriers to generic pharmaceutical price reduction.", "HOUSE OF REPRESENTATIVES,SENATE", 80000, null, 0, 0, "2023-10-19T11:15:58-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3060522"], "units": {}, "query_ms": 117.62721999548376, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}